[{"Assets_0_Q3_USD":5977475000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":182616000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":183214000.0,"StockholdersEquity_0_Q3_USD":4266149000.0,"RevenuesConverted_3_Q3_USD":1396465000.0,"RevenuesConverted_1_Q3_USD":408742000.0,"NetIncomeLossConverted_3_Q3_USD":-6182000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":183214000.0,"NetIncomeLossConverted_1_Q3_USD":-36494000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.03,"EarningsPerShareDiluted_1_Q3_USD":-0.2,"EarningsPerShareBasic_3_Q3_USD":-0.03,"EarningsPerShareBasic_1_Q3_USD":-0.2,"CommonStockSharesOutstanding_0_Q3_shares":183567424.0,"CommonStockSharesConverted_0_Q3_shares":183567424.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":293356000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":182616000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211029"}]